Last update :
28/04/2024
Anti-inflammatory   Prednisone  
Oral solution
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References Pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Prednisone     
Container Origine Excipient Temperature Storage Duration of stability References
Glass Powder 300 mg
® = Inresa
SyrSpend SF PH4® >> 60 ml
23-25°C Protect from light
60 Day
4077

Glass Powder 250 mg
Prednisone
Polysorbate 80
Oral Mix® >> 50 ml
25°C Protect from light
90 Day
2054

Glass Tablets 250 mg
® = Apo-prednisone®
Oral Mix® >> 50 ml
25°C Protect from light
90 Day
2054

Glass Powder 250 mg
Prednisone
Polysorbate 80
Oral Mix® >> 50 ml
5°C Protect from light
90 Day
2054

Glass Tablets 250 mg
® = Apo-prednisone®
Oral Mix® >> 50 ml
5°C Protect from light
90 Day
2054

Plastic bottle Powder 132 mg
® = ?
SyrSpend SF PH4® >> 100 mL
2-8°C Not specified
30 Day
3810

Plastic bottle Powder 140 mg
® = ?
SyrSpend SF PH4 Cherry® >> 100 mL
2-8°C Not specified
30 Day
3810

Plastic bottle Powder 132 mg
® = ?
SyrSpend SF PH4® >> 100 mL
25°C Not specified
30 Day
3810

Plastic bottle Powder 140 mg
® = ?
SyrSpend SF PH4 Cherry® >> 100 mL
25°C Not specified
30 Day
3810

Syringe Powder 250 mg
Prednisone
Polysorbate 80
Oral Mix® >> 50 ml
25°C Protect from light
90 Day
2054

Syringe Tablets 5 mg
® = Apo-prednisone®
Oral Mix® >> 1 ml
25°C Protect from light
90 Day
2054

Syringe Powder 250 mg
Prednisone
Polysorbate 80
Oral Mix® >> 50 ml
5°C Protect from light
90 Day
2054

Syringe Tablets 5 mg
® = Apo-prednisone®
Oral Mix® >> 1 ml
5°C Protect from light
90 Day
2054


  Mentions Légales